Jie-Lin Qi

S-1 plus CIK as second-line treatment for advanced pancreatic cancer

Meng Wang, Shi Sheng-bin, Jie-Lin Qi et al. · Medical Oncology · 2013 · 32 citations

Medicine, Oncology, Pharmacology +8

MicroRNA 25 , microRNA 145 , and microRNA 210  as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations

Shengbin Shi, Meng Wang, Jing Tian et al. · Translational research · 2015 · 31 citations

Medicine, Molecular Medicine, Oncology +17

Efficacy of Erlotinib Plus Dendritic Cells and Cytokine-induced Killer Cells in Maintenance Therapy of Advanced Non–Small Cell Lung Cancer

Shengbin Shi, Xiaoyong Tang, Jing Tian et al. · Journal of Immunotherapy · 2014 · 30 citations

Medicine, Oncology, Pharmacology +15

Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI

Ronghang Hu, Shengbin Shi, Jie-Lin Qi et al. · Medical Oncology · 2014 · 13 citations

Medicine, Immunology, Oncology +14